These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31614000)

  • 21. Comparison of intraluminal radiofrequency ablation and stents vs. stents alone in the management of malignant biliary obstruction.
    Cui W; Wang Y; Fan W; Lu M; Zhang Y; Yao W; Li J
    Int J Hyperthermia; 2017 Nov; 33(7):853-861. PubMed ID: 28540797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional disparities affect treatment and survival of patients with intrahepatic cholangiocarcinoma--a Texas Cancer Registry analysis.
    Kneuertz PJ; Kao LS; Ko TC; Wray CJ
    J Surg Oncol; 2014 Sep; 110(4):416-21. PubMed ID: 24889699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma.
    Panjala C; Nguyen JH; Al-Hajjaj AN; Rosser BA; Nakhleh RE; Bridges MD; Ko SJ; Buskirk SJ; Kim GP; Harnois DM
    Liver Transpl; 2012 May; 18(5):594-601. PubMed ID: 22140024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis.
    Hyder O; Marsh JW; Salem R; Petre EN; Kalva S; Liapi E; Cosgrove D; Neal D; Kamel I; Zhu AX; Sofocleous CT; Geschwind JF; Pawlik TM
    Ann Surg Oncol; 2013 Nov; 20(12):3779-86. PubMed ID: 23846786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoradiation Therapy for Unresected Extrahepatic Cholangiocarcinoma: A Propensity Score-Matched Analysis.
    Torgeson A; Lloyd S; Boothe D; Cannon G; Garrido-Laguna I; Whisenant J; Lewis M; Kim R; Scaife C; Tao R
    Ann Surg Oncol; 2017 Dec; 24(13):4001-4008. PubMed ID: 29043526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EVI1 expression is associated with aggressive behavior in intrahepatic cholangiocarcinoma.
    Tanaka M; Shibahara J; Ishikawa S; Ushiku T; Morikawa T; Shinozaki-Ushiku A; Hayashi A; Misumi K; Tanaka A; Katoh H; Sakuma K; Kokudo T; Inagaki Y; Arita J; Sakamoto Y; Hasegawa K; Fukayama M
    Virchows Arch; 2019 Jan; 474(1):39-46. PubMed ID: 30349952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thermal Ablation for Intrahepatic Cholangiocarcinoma in Cirrhosis: Safety and Efficacy in Non-Surgical Patients.
    Díaz-González Á; Vilana R; Bianchi L; García-Criado Á; Rimola J; Rodríguez de Lope C; Ferrer J; Ayuso C; Da Fonseca LG; Reig M; Forner A
    J Vasc Interv Radiol; 2020 May; 31(5):710-719. PubMed ID: 31685360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum gamma-glutamyl transferase levels affect the prognosis of patients with intrahepatic cholangiocarcinoma who receive postoperative adjuvant transcatheter arterial chemoembolization: A propensity score matching study.
    Lu Z; Liu S; Yi Y; Ni X; Wang J; Huang J; Fu Y; Cao Y; Zhou J; Fan J; Qiu S
    Int J Surg; 2017 Jan; 37():24-28. PubMed ID: 27756646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database.
    Rajyaguru DJ; Borgert AJ; Smith AL; Thomes RM; Conway PD; Halfdanarson TR; Truty MJ; Kurup AN; Go RS
    J Clin Oncol; 2018 Feb; 36(6):600-608. PubMed ID: 29328861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addition of thermal ablation to systemic chemotherapy for the treatment of unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis.
    Yan X; Zhuang LP; Ning ZY; Wang P; Meng ZQ
    Expert Rev Gastroenterol Hepatol; 2022 Jan; 16(1):81-88. PubMed ID: 34937481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.
    Ecker BL; Vining CC; Roses RE; Maggino L; Lee MK; Drebin JA; Fraker DL; Vollmer CM; Datta J
    Ann Surg Oncol; 2017 Dec; 24(13):3926-3933. PubMed ID: 28952140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
    Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
    Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiofrequency ablation in the treatment of unresectable intrahepatic cholangiocarcinoma: systematic review and meta-analysis.
    Han K; Ko HK; Kim KW; Won HJ; Shin YM; Kim PN
    J Vasc Interv Radiol; 2015 Jul; 26(7):943-8. PubMed ID: 25899049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conditional Probability of Long-term Survival After Liver Resection for Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 535 Patients.
    Spolverato G; Kim Y; Ejaz A; Alexandrescu S; Marques H; Aldrighetti L; Gamblin TC; Pulitano C; Bauer TW; Shen F; Sandroussi C; Poultsides G; Maithel SK; Pawlik TM
    JAMA Surg; 2015 Jun; 150(6):538-45. PubMed ID: 25831462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype.
    Kim Y; Lee K; Jeong S; Wen X; Cho NY; Kang GH
    Virchows Arch; 2019 Jul; 475(1):49-58. PubMed ID: 30610381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoscopic radiofrequency ablation plus a novel oral 5-fluorouracil compound versus radiofrequency ablation alone for unresectable extrahepatic cholangiocarcinoma.
    Yang J; Wang J; Zhou H; Wang Y; Huang H; Jin H; Lou Q; Shah RJ; Zhang X
    Gastrointest Endosc; 2020 Dec; 92(6):1204-1212.e1. PubMed ID: 32437711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis of Intrahepatic Cholangiocarcinomas with HBV Infection is Better than Those with Hepatolithiasis After R0 Liver Resection: A Propensity Score Matching Analysis.
    Wang Q; Li J; Lei Z; Wu D; Si A; Wang K; Wang Y; Wan X; Lau WY; Shen F
    Ann Surg Oncol; 2017 Jun; 24(6):1579-1587. PubMed ID: 28058554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-surgical management of patients with intrahepatic cholangiocarcinoma in the United States, 2004-2015: an NCDB analysis.
    Kolarich AR; Shah JL; George TJ; Hughes SJ; Shaw CM; Geller BS; Grajo JR
    J Gastrointest Oncol; 2018 Jun; 9(3):536-545. PubMed ID: 29998019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study.
    Shaib YH; Davila JA; Henderson L; McGlynn KA; El-Serag HB
    J Clin Gastroenterol; 2007; 41(10):911-7. PubMed ID: 18090160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
    Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
    J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.